Abstract:In the last few years, next-generation sequencing (NGS)5 has revolutionized the approaches by which we interrogate the genetic causes of rare single-gene disorders (1). More recently, NGS has been rapidly moving into the clinical diagnostics arena and transforming the practice of molecular diagnostics testing. Many NGS-based tests for multigene panels are available in clinical laboratories. Now, proof-of-principle studies are demonstrating the feasibility of using exome sequencing for clinical testing (2–4). Dixon-Salazar et al. used exome sequencing to interrogate a cohort of 118 probands with recessive neurodevelopmental disorders and identified disease-causing mutations in 19% of the probands. Importantly, exome sequencing uncovered mutations in 10 probands (8% of the cohort) that altered the initial clinical diagnosis and led in some cases to a change in patient management (2). Calvo et al. tested 42 infants with mitochondrial diseases with the “MitoExome” (mitochondrial DNA plus exons of approximately 1000 nuclear genes) and confirmed that 10 patients (24% of the cohort) had pathogenic mutations. In addition, these investigators identified 2 novel disease-causing genes (3). Need et al. used exome sequencing in family trios to investigate patients with a broad range of phenotypic presentations and reported a 33% diagnostic yield: 4 of 12 patients with apparently causal mutations and 2 additional potentially novel disease-causing genes (4). Although the number of patients tested thus far by whole-exome sequencing (WES) or whole-genome sequencing (WGS) is still small, the data reported in these recent studies have defined the minimal diagnostic yields of such NGS-based clinical tests at their early stage of implementation, thus demonstrating the practicality of NGS-based tests. We anticipate that the clinical utility of NGS-based tests will improve further in the next few years and that more patients will benefit from improved diagnostic accuracy and more-appropriate treatment. Conventional molecular diagnostics tests evaluate a defined …

Whole Exome Sequencing in the Researches and Diagnosis of Monogenic Disorders

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

The application of whole-exome sequencing in the early diagnosis of rare genetic diseases in children: a study from Southeastern China

Exome and Whole-Genome Sequencing As Clinical Tests: a Transformative Practice in Molecular Diagnostics.

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Procedure Comparison Between Rapid and Standard Whole-Exome Data Interpretation for Clinical Diagnosis of Genetic Disorder

Clinical Application of Whole Exome Sequencing for Monogenic Disorders in PICU of China

Clinical application of whole-exome sequencing across clinical indications

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Ultra-rare renal diseases diagnosed with whole-exome sequencing: Utility in diagnosis and management

The Application of Whole−Exome Sequencing in Patients with FUO

Prenatal diagnosis of skeletal dysplasias using whole exome sequencing in China

PW02-001 - Exome Sequencing for Autoinflammatory Disorders

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Application of RNA Sequencing in Clinical Diagnosis of Mendelian Disease

[Application of whole exome sequencing technology in the diagnosis of hereditary eye diseases]

Effect of clinical whole exome sequencing in aetiological investigation and reproductive risk prediction for a couple with monogenic inherited diseases

Whole Exome Sequencing as a First-Line Molecular Genetic Test in Developmental and Epileptic Encephalopathies

Identification of extremely rare mitochondrial disorders by whole exome sequencing

Promises, pitfalls and practicalities of prenatal whole exome sequencing

Clinical use of whole exome sequencing in children with developmental delay/intellectual disability